hupo2017@conferencepartners.ie

Mark Baker

Mark Baker

Talk Title:
Tissue and plasma proteomics allows early stage colorectal cancer detection/stratification that improves patient outcome

Bio:

Mark Baker: Born 1956 Sydney and completed PhD 1985 at Macquarie University. Main research focus is biochemistry of proteins in human health/disease. Mark made stellar contributions to the growth of proteomics societies nationally, regionally and internationally from the outset, including a successful stint in the USA biotech industry. In 2004, he co-founded the Australasian Proteomics Society, was a founding AO-HUPO Councillor and foundation member of HUPO. Mark returned from the USA to grow Australia’s national proteome facility APAF as its CEO, securing major government support for systems biology infrastructure. Mark serves on the HUPO Board from 2005 until now. He was elected to the HUPO Executive in 2012 and served as the i8memdiate past HUPO President. in 2013. Mark co-chaired the 9th HUPO World Congress in Sydney when the Human Proteome Project was launched. He has been a chair/member of many HUPO initiatives and management committees, as well as sitting on prestigious journals’ Editorial Boards and industry Advisory Boards. Mark was recognised in 2012 with the HUPO Distinguished Service Award. He has published ~150 peer-reviewed papers, graduated more than 38Honours/PhD graduates and is the inventor of 5 technology patents. He remains an advocate for industry:academic collaborations, media engagement and promotion of young researcher career paths. He is passionate about cooking, epicure, fishing, Rugby and biomedical research.

Abstract:

Mark Baker: Born 1956 Sydney and completed PhD 1985 at Macquarie University. Main research focus is biochemistry of proteins in human health/disease. Mark made stellar contributions to the growth of proteomics societies nationally, regionally and internationally from the outset, including a successful stint in the USA biotech industry. In 2004, he co-founded the Australasian Proteomics Society, was a founding AO-HUPO Councillor and foundation member of HUPO. Mark returned from the USA to grow Australia’s national proteome facility APAF as its CEO, securing major government support for systems biology infrastructure. Mark serves on the HUPO Board from 2005 until now. He was elected to the HUPO Executive in 2012 and served as the i8memdiate past HUPO President. in 2013. Mark co-chaired the 9th HUPO World Congress in Sydney when the Human Proteome Project was launched. He has been a chair/member of many HUPO initiatives and management committees, as well as sitting on prestigious journals’ Editorial Boards and industry Advisory Boards. Mark was recognised in 2012 with the HUPO Distinguished Service Award. He has published ~150 peer-reviewed papers, graduated more than 38Honours/PhD graduates and is the inventor of 5 technology patents. He remains an advocate for industry:academic collaborations, media engagement and promotion of young researcher career paths. He is passionate about cooking, epicure, fishing, Rugby and biomedical research.

msb